ArticleHepatology international2021

Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B.

Hye Won Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.